Lilly Focuses On ‘Traditional’ Approval For Donanemab, Increased Mounjaro Production

 
• By Joseph Haas
  
Fourth quarter
Lilly intends to increase production capacity for Mounjaro ahead of obesity approval • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business